Gastro-intestinal stromal tumours (unresectable/metastatic) - imatinib (review)
Imatinib for the treatment of unresectable and/or metastatic gastrointestinal stromal tumours (part review of TA86)
| Status: | In progress |
| Expected date of issue: | TBC |
| Wave: | R |
| Process: | MTA |
Topic area:
|
NICE project team
| Executive Lead: | TBC |
| Technical Lead: | Joao Vieira |
| Communications manager: | TBC |
| Project manager: | Jeremy Powell |
| Assessment group: | Aberdeen Health Technology Assessment Group |
| Top |
Provisional schedule
| Consultation on draft scope by stakeholders: | 25 June 2009 | |
| Closing date for invited submissions / evidence submission: | 23 November 2009 | |
| 1st appraisal committee meeting: | 02 June 2010 | |
| 2nd appraisal committee meeting | 04 August 2010 |
| Top |
Consultees and Commentators
|
To be confirmed |
| Top |
